Trial
TN10 Teplizumab
TrialNet 10: anti-CD3 Fc-silent (teplizumab) vs placebo in relatives with Stage 2 T1DM (≥2 autoantibodies + dysglycaemia).
Also called: TN10, teplizumab T1DM trial, TrialNet 10
In short
- 1What it is: a trial in therapies and applications.
- 2How it connects: acts on 1 and is affected by 1 concepts — mostly 2 therapy.
- 3Where it sits: trial on the 15-step immune chain.
What it does
T1DM onset delayed median 25 months (HR 0.41, p=0.006).
Its connections at a glance
Each dot is a concept directly linked to TN10 Teplizumab. Colours show the kind of concept.
Sources & evidenceloading…
Loading reviewed sources…
Graph ID TR008 · concept status: established. Select any connection above to inspect evidence for that specific link.